|Bid||11.82 x 800|
|Ask||11.95 x 1800|
|Day's Range||11.57 - 12.87|
|52 Week Range||1.12 - 18.39|
|Beta (3Y Monthly)||0.39|
|PE Ratio (TTM)||1,327.78|
|Earnings Date||May 11, 2017 - May 12, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||23.33|
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, joined the MSCI USA Microcap Index at the conclusion of the MSCI indexes semi-annual reconstitution, effective after the U.S. market closes today, according to the MSCI website. “Joining the MSCI USA Microcap Index represents another major market milestone for OptimizeRx after our up-listing to Nasdaq earlier this year,” said OptimizeRx CEO, William Febbo.
ROCHESTER, MI / ACCESSWIRE / November 28, 2018 / OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 11th Annual LD Micro Main Event institutional investor conference being held on December 4-6, 2018 at the Luxe Sunset Bel Air Hotel in Bel Air, California. William Febbo, CEO of OptimizeRx, is scheduled to present on Tuesday, December 4, at 1:30 p.m. Pacific time, with one-on-one meetings with institutional analysts and investors. The presentation will be also webcast live and available for replay here and via the investor relations section of the company's website at www.optimizerx.com.
The big shareholder groups in OptimizeRx Corporation (NASDAQ:OPRX) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership Read More...
NEW YORK, Nov. 15, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to ring the Nasdaq Stock Market Closing Bell on Friday, November 16, to commemorate the company’s recent market uplisting. In honor of the occasion, William Febbo, CEO of OptimizeRx, will ring the closing bell at the Nasdaq Market site in Times Square, where he will be joined by other members of the OptimizeRx team.
ROCHESTER, Mich., Nov. 05, 2018 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.
OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in the 4th Annual ROTH Technology Corporate Access Day being hosted by ROTH Capital Partners on November 14, 2018 at the Empire Steak House in New York City. OptimizeRx CEO William Febbo will discuss a number of topics, including the company’s results for the third quarter of 2018, recent acquisition of CareSpeak Communications, and the growth of the company’s digital health network. The network is the largest of its kind, reaching more than half of the ambulatory patient market in the U.S.
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has acquired CareSpeak Communications, a leader in interactive health messaging for improved medication adherence and care coordination. OptimizeRx bridges the communication gap between pharma and providers with its digital health messaging platform that is delivered through a nationwide network of leading electronic health record (EHR) and ePrescribing providers.
Zero-debt allows substantial financial flexibility, especially for small-cap companies like OptimizeRx Corporation (NASDAQ:OPRX), as the company does not have to adhere to strict debt covenants. However, it also faces higher Read More...
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to speak at the 12th Annual Digital Pharma East conference being held at the Pennsylvania Convention Center in Philadelphia on October 16-19, 2018. Bringing together more than 1,000 participants, this conference will feature latest case studies and senior-level discussions with pharma companies, health systems, physicians, health-tech companies, startups and non-traditional healthcare companies involved in digital health. A plenary session, “Addressing Medication Adherence to Improve Quality of Care,” will be co-hosted by Miriam Paramore, president of OptimizeRx, at 5:00 p.m. Eastern time on October 17.
The Digital Issue of the Fall 2018 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / October 9, 2018 / SNN ...
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
ROCHESTER, Mich., Sept. 27, 2018-- OptimizeRx Corp., a leading provider of digital health messaging for the pharmaceutical industry, has partnered with Medicom Health, a software company that creates evidence-based ...
NEW YORK, NY / ACCESSWIRE / August 7, 2018 / OptimizeRx Corporation (NASDAQ: OPRX ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern Time. ...